IDENTIFICATION OF CIRRHOTIC CARDIOMYOPATHY
Keywords:
Liver cirrhosis, hepatitis virus, cardiomyopathy, diagnosticsAbstract
Despite the advances made in the study of liver cirrhosis (LC), it remains an extremely important medical and social problem. There is a continuous increase in persistent disability and, especially, mortality from chronic liver disease, which is among the top ten most common causes of death in the population [3]. It is important to improve the methods of early diagnostics of structural and functional changes in the heart, both for predicting the course of the disease and for possible correction of treatment, including therapeutic and surgical approaches. The relevance of further study of the state of cardiohemodynamics in LC is also due to the need to clarify the criteria for the so-called "cirrhotic cardiomyopathy" (CCM) proposed at the World Congress of Gastroenterologists in 2005 [2]. This term refers to the presence of cardiac dysfunction in patients with CP, characterized by suppression of contractile reactivity to stress and/or changes in diastolic relaxation, with typical electrophysiological manifestations in the absence of any other cardiac pathology [4]
References
Alqahtani, S. A. Cirrhotic cardiomyopathy / S. A. Alqahtani, T. R. Fouad, S. S. Lee // Semin. Liver Dis. – 2008. – Vol. 28. – P. 59–69.
American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Peripheral Vascular Disease, American Heart Association, American College of Cardiology Foundation. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientifi c statement from the American Heart Association and the American College of Cardiology Foundation: endorsed by the American Society of Transplant Surgeons, American Society of Transplantation, and National Kidney Foundation / K. L. Lentine [et al.] // Circulation. – 2012. – Vol. 126. – P. 617–663.
Bayley, T. J. The circulatory changes in patients with cirrhosis of the liver at rest and during exersize / T. J. Bayley, N. Segel, J. M. Bishop // Clin. Sci. – 1964. – Vol. 26. – P. 227–235.
Cardiac alterations in cirrhosis: reversibility after liver transplantation / M. Torregrosa [et al.] // J. Hepatol. – 2005. – Vol. 42. – P. 68–74.
Cardiac and proinfl ammatory markers predict prognosis in cirrhosis / S. Wiese [et al.] // Liver Int. – 2014. – Vol. 34. – P. e19–e30.
Cardiac dysfunction during liver transplantation: incidence and preoperative predictors / C. Ripoll [et al.] // Transplantation. – 2008. – Vol. 85. – P. 1766–1772. 12. Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease / M. Merli [et al.] // Eur. J. Int. Med. – 2013. – Vol. 24. – P. 172–176.
Matsumori A. Hepatitis C virus infection and cardiomyopathies. Circ Res 96: 2005; 96: 144. 8.Поражения сердца при инфекционных болезнях / Ю.П. Финогеев [и др.]. – СПб: Фолиант, 2003. – 251 с.
